Pharmaton   Report issue

For profit Phase 3
Founded: Dublin Ireland (1942)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT00144235
First Marketed Drug
1983
epinephrine (levophed)
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

PHARMATON

Active Ingredients

Marketed Drugs (2)

epinephrine (levophed) (1983)

lidocaine (xylocaine) (1983)

Drugs in Phase 3 Trials (1)

multivitamins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 3)

Mental Fatigue (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1